1-6 of 6
heart disease risk factors
Close
Sort by
Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.
https://doi.org/10.1182/asheducation-2018.1.264
Published: 2018
Journal Articles

Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy

Mary C. Barber, Michael J. Mauro, Javid Moslehi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 110–114.
https://doi.org/10.1182/asheducation-2017.1.110
Published: 2017
Journal Articles

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Flora E. van Leeuwen, Andrea K. Ng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 323–330.
https://doi.org/10.1182/asheducation-2016.1.323
Published: 2016
Journal Articles

Management of Essential Thrombocythemia

Francisco Cervantes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 215–221.
https://doi.org/10.1182/asheducation-2011.1.215
Published: 2011
Journal Articles

The Cardiovascular Pharmacology of COX-2 Inhibition

Susanne Fries, Tilo Grosser
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 445–451.
https://doi.org/10.1182/asheducation-2005.1.445
Published: 2005
Journal Articles

Chronic Myeloproliferative Disorders

Jerry L. Spivak, Giovanni Barosi, Gianni Tognoni, Tiziano Barbui, Guido Finazzi, Roberto Marchioli, Monia Marchetti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 200–224.
https://doi.org/10.1182/asheducation-2003.1.200
Published: 2003